Naveen Kalra
Papers
1
Total Citations
13
H-Index
1
About
Naveen Kalra is a leading researcher in nuclear medicine and oncologic imaging, with a focused expertise in the use of 18F-FDG PET/CT for the evaluation and management of hematologic malignancies, particularly non-Hodgkin’s lymphoma (NHL). His major contributions center on refining the diagnostic accuracy of post-therapy PET/CT imaging, a critical challenge in oncology. In his highly cited 2017 work, Kalra pioneered the use of an automated robotic biopsy arm to perform PET/CT-guided biopsies of post-therapy lesions in NHL patients. This study directly addressed the problem of false-positive scans by histopathologically confirming the nature of residual metabolic activity, thereby establishing a more precise positive predictive value for this imaging modality. By integrating advanced robotic technology with functional imaging, his research has provided a robust framework for distinguishing true residual disease from treatment-related inflammation, significantly impacting clinical decision-making. With over a decade of influence, his work has been cited extensively (13+ citations for this key paper alone), shaping protocols for response assessment and recurrence surveillance. Kalra’s innovative methodological approach stands as a notable achievement, bridging the gap between imaging findings and definitive tissue diagnosis in lymphoma care.
Research Focus
Key Achievements
Top Papers
- 1